- Home
- PYXS vs DOUG Comparison
PYXS vs DOUG Comparison
Compare PYXS & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PYXS | DOUG |
|---|---|---|
| Founded | 2018 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 219.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PYXS | DOUG |
|---|---|---|
| Price | $1.78 | $2.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 433.2K |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,820,000.00 | ★ $1,030,928,000.00 |
| Revenue This Year | N/A | $17.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.67 |
| 52 Week Low | $0.83 | $1.48 |
| 52 Week High | $5.55 | $3.20 |
Technical Indicators
Market Signals| Indicator | PYXS | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 67.66 |
| Support Level | $1.03 | $2.42 |
| Resistance Level | $2.17 | $2.61 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | 0.16 | 0.05 |
| Stochastic Oscillator | 66.22 | 75.00 |
Price Performance
Historical ComparisonAbout PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.